Tectonic Therapeutic, Inc. — Director's Dealing 2019

Mar 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2019-03-05

Reporting Person: MACKAY GEOFFREY (Director, See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-05	Stock Option (Right to Buy)	$15.00	A	100000	Acquired	2029-03-04	Common Stock (100000)	Direct

Footnotes

F1: 25% of the shares vest on March 5, 2020, and the remaining 75% shall vest in equal monthly installments thereafter over a three-year period.